# Efficacy and Safety of Postoperative Concurrent Chemoradiotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma: A Multicenter Prospective Phase II Study

> **NCT07636824** · PHASE2 · RECRUITING · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 92 (estimated)

## Conditions studied

- Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

## Interventions

- **RADIATION:** Postoperative radiotherapy
- **DRUG:** Capecitabine or S-1

## Key facts

- **NCT ID:** NCT07636824
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-16
- **Primary completion:** 2029-02-28
- **Final completion:** 2029-05-30
- **Target enrollment:** 92 (ESTIMATED)
- **Last updated:** 2026-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07636824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07636824, "Efficacy and Safety of Postoperative Concurrent Chemoradiotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma: A Multicenter Prospective Phase II Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07636824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*